by Those with teenagers wishing for the greater travel freedom likely to come with proof of vaccination may have cause for hope. On 7 May 2021, Pfizer submitted an authorisation application to Swissmedic, Switzerland’s drug approval agency, for use of its vaccine against Covid-19 on those aged 12 to 15 years old. © Jovanmandic | Dreamstime.com - Click to enlarge The application asks for the authorisation of the vaccine, which is currently being used on adults in Switzerland, to be extended to include the age group of 12-15-year-olds. Swissmedic will review the application using a rolling procedure. This means that Pfizer can submit the latest data continuously without having to wait for the conclusive results from the clinical studies. The duration of the rolling
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter
This could be interesting, too:
Vibhu Vikramaditya writes Navigating the Slippery Slope: How Hoover’s Interventions Paved the Way for the Great Depression
Ryan McMaken writes Frédéric Bastiat Was a Radical Opponent of War and Militarism
Douglas French writes Millennials: In Costco We Trust
Vasil Georgiev writes Luftfahrtindustrie: Rückblick auf 2023 und Prognose für 2024
Those with teenagers wishing for the greater travel freedom likely to come with proof of vaccination may have cause for hope. On 7 May 2021, Pfizer submitted an authorisation application to Swissmedic, Switzerland’s drug approval agency, for use of its vaccine against Covid-19 on those aged 12 to 15 years old.
© Jovanmandic | Dreamstime.com - Click to enlarge
The application asks for the authorisation of the vaccine, which is currently being used on adults in Switzerland, to be extended to include the age group of 12-15-year-olds.
Swissmedic will review the application using a rolling procedure. This means that Pfizer can submit the latest data continuously without having to wait for the conclusive results from the clinical studies. The duration of the rolling review will depend on the completeness of the data submitted and the results of the clinical trials.
A week earlier, Pfizer/BioNTech submitted corresponding applications to the EMA (European Medicines Agency) and the FDA (US Food and Drug Administration).
On 10 May 2021, the US Federal Drug Administration (FDA) approved the emergency use of Pfizer/BioNTech vaccine on adolescents aged 12 to 15 years old.
The risk of someone in this age band dying from Covid-19 is very low. However, there is evidence that adolescents are involved in transmitting the virus, and evidence suggests vaccination significantly reduces the chance of someone spreading the SARS-CoV-2 virus. A recent study by Public Health England suggests a single vaccine dose might cut the likelihood of transmission by nearly half.
You Might Also Like
Weekly SNB Sight Deposits and Speculative Positions: Inflation is there, CHF must Rise
2021-05-17
Update May 17 2021: SNB intervening. Sight Deposits have risen by +2.7 bn CHF, this means that the SNB is intervening and buying Euros and Dollars: The change is +2.7 bn. compared to last week.
Covid: 13,465 new cases in Switzerland this week
2021-05-02
This week, saw 13,465 new Covid-19 cases in Switzerland, down 5% from a week before (14,110) continuing the 5% slow down in growth of new numbers experienced last week.
© Andrii Kozlytskyi | Dreamstime.comThe 7-day average is currently 1,924, dipping below the level of 2,000 for the first time since 11 April 2021.
By 30 April 2021, 10.8% of Switzerland’s population was fully vaccinated, up from 9.6% a week earlier. This week, the number of doses administered per 100 people rose from 26.4 to 30.6, leaving Switzerland trailing behind the EU (32.1 per 100), the UK (70.9) and US (70.2).
By the end of this week, Switzerland’s reproduction rate was below 1.00 overall (0.98) with a few hotspots in central and far eastern Switzerland.
Currently, 25% of hospital beds remain
IMF praises Switzerland’s economic response to the pandemic
2021-04-10
According to the International Monetary Fund (IMF), Switzerland has economically navigated the Covid-19 pandemic well so far. In 2020, the Swiss economy shrank by 2.9%, far less than many other advanced European economies. France (-8.2%), Germany (-4.9%), Italy (-8.9%) and the UK (-9.9%) all performed far worse.
Covid: new negative test requirement for entering Switzerland
2021-02-11
From Monday 8 February 2021, many people entering Switzerland require a negative PCR test. Currently, there are restrictions on who can enter Switzerland. Generally, only those with a Swiss passport, a valid Swiss residence or cross-border permit, and those who are citizens of an EU or EFTA nation are allowed to enter Switzerland under the current Covid-19 restrictions.
Covid: a majority of Swiss in favour of closing ski lifts
2021-01-29
According to a recent survey by Swiss media company Tamedia, 55% of the population is in favour of closing the country’s ski domains if the Covid-19 situation gets worse. reported the newspaper 20 Minutes.
Covid: retroactive quarantine for those arriving from the UK and South Africa
2020-12-22
Following the discovery of a new, more contagious variant of the coronavirus in the UK and South Africa, the Federal Council today decided to take steps to prevent the further spread of this new virus strain.
Covid, December 18: 22 percent of Geneva tests positive for antibodies
2020-12-18
An update to an antibody study conducted by HUG and UNIGE suggests that 22% of Geneva’s population had been exposed to the SARS-CoV-2 virus by December 2020.
Coronavirus biggest concern among Swiss, according to survey
2020-11-21
The coronavirus pandemic and its consequences rank at the top of the list of Swiss concerns in 2020, according to a recent survey.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter